Scarborough Advisors’s Soligenix SNGX Stock Holding History

Scarborough Advisors’s Portfolio SNGX Stock Details SNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4	Closed	-$47	–	676
2023 Q4	$47	Buy	+4	New	+$35	﹤0.01%	712

Other funds holding SNGX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PMFA

Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return

Scarborough Advisors's SNGX Position: Q1 2024 in Review

Scarborough Advisors sold out of Soligenix (SNGX) in Q1 2024, closing a stake of 4 shares — an estimated $47 sold.

Scarborough Advisors first reported a position in SNGX in Q4 2023 and held it in 1 quarter. The position peaked at $47 in Q4 2023. 16 funds tracked by Wall St. Rank hold SNGX as of Q1 2024.

Scarborough Advisors reported no remaining Soligenix position as of Q1 2024 after selling out during the quarter.
Scarborough Advisors sold 4 Soligenix shares in Q1 2024, an estimated $47.
Scarborough Advisors first reported a position in Soligenix in Q4 2023 and held it in 1 quarter.
Scarborough Advisors's Soligenix position peaked at $47 in Q4 2023.
16 funds tracked by Wall St. Rank held Soligenix as of Q1 2024.

Based on Scarborough Advisors's 13F filing for Q1 2024, filed 10 May 2024.